Advances in non-invasive assessment of hepatic fibrosis
R Loomba, LA Adams - Gut, 2020 - gut.bmj.com
Liver fibrosis should be assessed in all individuals with chronic liver disease as it predicts
the risk of future liver-related morbidity and thus need for treatment, monitoring and …
the risk of future liver-related morbidity and thus need for treatment, monitoring and …
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
[PDF][PDF] 中国人群肝癌筛查指南(2022, 北京)
赫捷， 陈万青， 沈洪兵， 李霓， 曲春枫， 石菊芳， 孙凤… - 中华肿瘤杂志, 2022 - dzrmyy.com
中国人群的肝癌存在生存率低, 死亡率高的情况, 如何有效降低肝癌相关负担仍是中国公共卫生
和慢性病防控领域亟待解决的重大问题, 而肝癌人群筛查策略优化是值得持续探索的重要抓手和 …
和慢性病防控领域亟待解决的重大问题, 而肝癌人群筛查策略优化是值得持续探索的重要抓手和 …
Why, who and when to start treatment for chronic hepatitis B infection
Chronic hepatitis B remains a major global health challenge due to morbidity and mortality
from hepatocellular carcinoma and complications of liver cirrhosis. Current treatment …
from hepatocellular carcinoma and complications of liver cirrhosis. Current treatment …
Survival analysis and development of a prognostic nomogram for patients with hepatitis B virus-associated hepatocellular carcinoma
J Wang, K Wang, C Chen, Y Xiong, C Guo, C Wang… - Heliyon, 2023 - cell.com
Background and aims Hepatitis B virus (HBV) is a common cause of hepatocellular
carcinoma (HCC) in China, and this study aimed to identify high-risk factors for overall …
carcinoma (HCC) in China, and this study aimed to identify high-risk factors for overall …
On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in HBV‐related compensated cirrhosis
S Wu, Y Kong, H Piao, W Jiang, W Xie… - Liver …, 2018 - Wiley Online Library
Abstract Background & Aims It is unclear whether liver stiffness measurement (LSM)
dynamic changes after anti‐HBV treatment could predict the risk of liver‐related events (LRE …
dynamic changes after anti‐HBV treatment could predict the risk of liver‐related events (LRE …
[HTML][HTML] China guideline for liver cancer screening (2022, Beijing)
HE Jie, C Wanqing, S Hongbing, LI Ni, QU Chunfeng… - 临床肝胆病杂志, 2022 - lcgdbzz.com
In China, the survival rate of liver cancer remains low while the mortality rate is high.
Effectively reducing the burden of liver cancer is still a major challenge in the field of public …
Effectively reducing the burden of liver cancer is still a major challenge in the field of public …
Prevalence and risk factors of cardiovascular disease in patients with chronic hepatitis B
Background The association between chronic hepatitis B (CHB) and cardiovascular disease
(CVD) remains unclear. We investigated the prevalence and risk factors of CVD in patients …
(CVD) remains unclear. We investigated the prevalence and risk factors of CVD in patients …
ALT is not associated with achieving subcirrhotic liver stiffness and HCC during entecavir therapy in HBV-related cirrhosis
Background & Aims We investigated whether baseline and on-treatment alanine
aminotransferase (ALT) levels during entecavir (ETV) therapy are associated with achieving …
aminotransferase (ALT) levels during entecavir (ETV) therapy are associated with achieving …
[图书][B] Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)
H Ding, H Tu, C Qu, G Cao, H Zhuang, P Zhao, X Xu… - 2021 - books.google.com
The age-adjusted incidence of primary liver cancer (PLC) has been declining in China.
However, PLC cases in China account for 55% globally. The disease burden is still high and …
However, PLC cases in China account for 55% globally. The disease burden is still high and …